Literature DB >> 16895890

Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study.

Ivon E J Milder1, Edith J M Feskens, Ilja C W Arts, H Bas Bueno-de-Mesquita, Peter C H Hollman, Daan Kromhout.   

Abstract

BACKGROUND: Plant lignans are converted to enterolignans that have antioxidant and weak estrogen-like activities, and therefore they may lower cardiovascular disease and cancer risks.
OBJECTIVE: We investigated whether the intakes of 4 plant lignans (lariciresinol, pinoresinol, secoisolariciresinol, and matairesinol) were inversely associated with coronary heart disease (CHD), cardiovascular diseases (CVD), cancer, and all-cause mortality.
DESIGN: The Zutphen Elderly Study is a prospective cohort study in which 570 men aged 64-84 y were followed for 15 y. We recently developed a database and used it to estimate the dietary intakes of 4 plant lignans. Lignan intake was related to mortality with the use of Cox proportional hazards analysis.
RESULTS: The median total lignan intake in 1985 was 977 microg/d. Tea, vegetables, bread, coffee, fruit, and wine were the major sources of lignan. The total lignan intake was not related to mortality. However, the intake of matairesinol was inversely associated with CHD, CVD, and all-cause mortality (P </= 0.05 for all) and cancer (P = 0.06). Multivariate-adjusted rate ratios (95% CI) per 1-SD increase in intake were 0.72 (0.53, 0.98) for CHD, 0.83 (0.69, 1.00) for CVD, 0.86 (0.76, 0.97) for all-cause mortality, and 0.81 (0.65, 1.00) for cancer.
CONCLUSIONS: Total lignan intake was not associated with mortality. The intake of matairesinol was inversely associated with mortality due to CHD, CVD, cancer, and all causes. We cannot exclude the possibility that the inverse association between matairesinol intake and mortality is due to an associated factor, such as wine consumption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895890     DOI: 10.1093/ajcn/84.1.400

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

Review 1.  Dietary lignans: physiology and potential for cardiovascular disease risk reduction.

Authors:  Julia Peterson; Johanna Dwyer; Herman Adlercreutz; Augustin Scalbert; Paul Jacques; Marjorie L McCullough
Journal:  Nutr Rev       Date:  2010-10       Impact factor: 7.110

Review 2.  Lignan exposure: a worldwide perspective.

Authors:  Lucia Rizzolo-Brime; Elida M Caro-Garcia; Cynthia A Alegre-Miranda; Mireia Felez-Nobrega; Raul Zamora-Ros
Journal:  Eur J Nutr       Date:  2021-11-20       Impact factor: 5.614

3.  Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Susan E McCann; Lilian U Thompson; Jing Nie; Joan Dorn; Maurizio Trevisan; Peter G Shields; Christine B Ambrosone; Stephen B Edge; Hsin-Fang Li; Christina Kasprzak; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2009-12-22       Impact factor: 4.872

4.  Lignan Intake and Risk of Coronary Heart Disease.

Authors:  Yang Hu; Yanping Li; Laura Sampson; Molin Wang; JoAnn E Manson; Eric Rimm; Qi Sun
Journal:  J Am Coll Cardiol       Date:  2021-08-17       Impact factor: 27.203

Review 5.  Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Johanna Rienks; Janett Barbaresko; Ute Nöthlings
Journal:  Nutrients       Date:  2017-04-22       Impact factor: 5.717

6.  Are Total and Individual Dietary Lignans Related to Cardiovascular Disease and Its Risk Factors in Postmenopausal Women? A Nationwide Study.

Authors:  Anna Maria Witkowska; Anna Waśkiewicz; Małgorzata Elżbieta Zujko; Danuta Szcześniewska; Urszula Stepaniak; Andrzej Pająk; Wojciech Drygas
Journal:  Nutrients       Date:  2018-07-04       Impact factor: 5.717

7.  The association between urinary genistein levels and mortality among adults in the United States.

Authors:  Carolyn Marcelo; Melissa Warwick; Catherine Marcelo; Rehan Qayyum
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.